Role For P120 Research Articles

Differential role for p120-catenin in regulation of TLR4 signaling in macrophages.

Activation of TLR signaling through recognition of pathogen-associated molecular patterns is essential for the innate immune response against bacterial and viral infections. We have shown that p120-catenin (p120) suppresses TLR4-mediated NF-кB signaling in LPS-challenged endothelial cells. In this article, we report that p120 differentially regulates LPS/TLR4 signaling in mouse bone marrow-derived macrophages. We observed that p120 inhibited MyD88-dependent NF-κB activation and release of TNF-α and IL-6, but enhanced TIR domain-containing adapter-inducing IFN-β-dependent IFN regulatory factor 3 activation and release of IFN-β upon LPS exposure. p120 silencing diminished LPS-induced TLR4 internalization, whereas genetic and pharmacological inhibition of RhoA GTPase rescued the decrease in endocytosis of TLR4 and TLR4-MyD88 signaling, and reversed the increase in TLR4-TIR domain-containing adapter-inducing IFN-β signaling induced by p120 depletion. Furthermore, we demonstrated that altered p120 expression in macrophages regulates the inflammatory phenotype of LPS-induced acute lung injury. These results indicate that p120 functions as a differential regulator of TLR4 signaling pathways by facilitating TLR4 endocytic trafficking in macrophages, and support a novel role for p120 in influencing the macrophages in the lung inflammatory response to endotoxin.

Abstract C50: Identification and characterization of novel p120/Kaiso target genes in invasive breast cancer

Abstract Previously, we have shown that mammary-specific loss of E-cadherin is causal to the formation of invasive lobular carcinoma and induces metastatic disease and anoikis resistance in mouse models for human ILC (mILC). Loss of E-cadherin has differential consequences for the associated catenins; while β-catenin is readily degraded, p120-catenin (p120) remains stable in the cytosol where it mediates anoikis resistance through MRIP-dependent indirect activation of Rho/ROCK signaling. In addition, p120 has the intrinsic capability to shuttle between the nucleus and the cytosol. Evidence for a functional role of nuclear p120 emerged when the transcriptional repressor Kaiso was discovered as a novel p120 interactor. Using a Kaiso-specific reporter, we have shown that basal Kaiso repression is significantly reduced in mILC cell lines compared to E-cadherin-proficient cell lines. In addition, overexpression of p120 in E-cadherin-proficient cells relieved Kaiso repression showing a causal role for p120 in modulating Kaiso activity. While p120/Kaiso signaling has been relatively well-studied in the context of developmental biology, limited data exists on the function and relevance of this pathway in cancer biology. To identify novel Kaiso target genes specifically involved in the context of breast cancer biology, we combined genome-wide expression profiling and computational analysis approaches. RNA was harvested from eight independent mILC cell lines cultured in both anchorage-independent and adherent setting and subsequently differentially displayed against itself. This approach yielded a subset of genes that showed upregulation in an anchorage-independent context and therefore could represent genes with a regulatory function in anoikis resistance. Computational analysis of the promoter region of these genes revealed 33 potential Kaiso target genes including the known Kaiso target Wnt11. First, binding of Kaiso to the Wnt11 promoter was confirmed using ChIP. Genetic ablation of Wnt11 significantly reduced survival in anchorage-independent mILC cell lines revealing a regulatory role for Wnt11 signaling in anoikis resistance. In addition, knockdown of Wnt11 reduced cell migration indicating a broad role for Wnt11 signaling in cancer invasion. Furthermore, RhoA levels were reduced upon Wnt11 knockdown suggesting that Wnt11-driven anoikis resistance and migration is driven through modulation of this GTPase. We hypothesize that loss of E-cadherin and subsequent nuclear shuttling of p120 in ILC relieves Kaiso-mediated transcriptional repression of multiple target genes including Wnt11. Autocrine Wnt11 signaling mediates anoikis resistance and migration through regulation of RhoA activity in ILC. Our future research will focus on delineating the p120/Kaiso pathway and identification and functional characterization of novel Kaiso target genes in invasive breast cancer. Citation Format: Robert A.H. van de Ven, Milou Tenhagen, Wouter Meuleman, Patrick W.B. Derksen. Identification and characterization of novel p120/Kaiso target genes in invasive breast cancer. [abstract]. In: Proceedings of the Third AACR International Conference on Frontiers in Basic Cancer Research; Sep 18-22, 2013; National Harbor, MD. Philadelphia (PA): AACR; Cancer Res 2013;73(19 Suppl):Abstract nr C50.

P120-Catenin Inhibits VE-Cadherin Internalization through a Rho-independent Mechanism

p120-catenin is a cytoplasmic binding partner of cadherins and functions as a set point for cadherin expression by preventing cadherin endocytosis, and degradation. p120 is known to regulate cell motility and invasiveness by inhibiting RhoA activity. However, the relationship between these functions of p120 is not understood. Here, we provide evidence that p120 functions as part of a plasma membrane retention mechanism for VE-cadherin by preventing the recruitment of VE-cadherin into membrane domains enriched in components of the endocytic machinery, including clathrin and the adaptor complex AP-2. The mechanism by which p120 regulates VE-cadherin entry into endocytic compartments is dependent on p120's interaction with the cadherin juxtamembrane domain, but occurs independently of p120's prevention of Rho GTPase activity. These findings clarify the mechanism for p120's function in stabilizing VE-cadherin at the plasma membrane and demonstrate a novel role for p120 in modulating the availability of cadherins for entry into a clathrin-dependent endocytic pathway.

An essential role for p120-catenin in Src- and Rac1-mediated anchorage-independent cell growth

p120-catenin regulates epithelial cadherin stability and has been suggested to function as a tumor suppressor. In this study, we used anchorage-independent growth (AIG), a classical in vitro tumorigenicity assay, to examine the role of p120 in a different context, namely oncogene-mediated tumorigenesis. Surprisingly, p120 ablation by short hairpin RNA completely blocked AIG induced by both Rac1 and Src. This role for p120 was traced to its activity in suppression of the RhoA–ROCK pathway, which appears to be essential for AIG. Remarkably, the AIG block associated with p120 ablation was completely reversed by inhibition of the downstream RhoA effector ROCK. Harvey-Ras (H-Ras)–induced AIG was also dependent on suppression of the ROCK cascade but was p120 independent because its action on the pathway occurred downstream of p120. The data suggest that p120 modulates oncogenic signaling pathways important for AIG. Although H-Ras bypasses p120, a unifying theme for all three oncogenes is the requirement to suppress ROCK, which may act as a gatekeeper for the transition to anchorage independence.

A novel role for p120 catenin in E-cadherin function.

Îndirect evidence suggests that p120-catenin (p120) can both positively and negatively affect cadherin adhesiveness. Here we show that the p120 gene is mutated in SW48 cells, and that the cadherin adhesion system is impaired as a direct consequence of p120 insufficiency. Restoring normal levels of p120 caused a striking reversion from poorly differentiated to cobblestone-like epithelial morphology, indicating a crucial role for p120 in reactivation of E-cadherin function. The rescue efficiency was enhanced by increased levels of p120, and reduced by the presence of the phosphorylation domain, a region previously postulated to confer negative regulation. Surprisingly, the rescue was associated with substantially increased levels of E-cadherin. E-cadherin mRNA levels were unaffected by p120 expression, but E-cadherin half-life was more than doubled. Direct p120–E-cadherin interaction was crucial, as p120 deletion analysis revealed a perfect correlation between E-cadherin binding and rescue of epithelial morphology. Interestingly, the epithelial morphology could also be rescued by forced expression of either WT E-cadherin or a p120-uncoupled mutant. Thus, the effects of uncoupling p120 from E-cadherin can be at least partially overcome by artificially maintaining high levels of cadherin expression. These data reveal a cooperative interaction between p120 and E-cadherin and a novel role for p120 that is likely indispensable in normal cells.

Up-regulated cytoplasmic expression, with reduced membranous distribution, of the src substrate p120(ctn) in gastric carcinoma.

p120(ctn) is a substrate of the tyrosine kinase pp60 src. Tyrosine kinases such as src localize to the adherens junctions and phosphorylate junctional proteins in both normal and transformed cells.(1) p120(ctn) forms a complex with E-cadherin at the adherens junction and is phosphorylated by ligands such as epidermal growth factor receptor as well as pp60 src. Phosphorylation of p120(ctn) has been shown to correlate with cell transformation. The aim of this study was to investigate in vivo expression of p120(ctn) in gastric carcinoma and to examine any relationship to pathological characteristics and patient survival. Immunohistochemical staining for p120(ctn) was performed in 68 gastric carcinoma specimens (19 diffuse, 49 intestinal type), in 22 lymph node metastases, and in gastric mucosal biopsies from 16 patients with gastric dysplasia and ten healthy controls. Up-regulation of p120(ctn) cytoplasmic staining was seen in six (37 per cent) of the gastric dysplasia cases and in 45 (66 per cent) tumours (89 per cent of diffuse and 57 per cent of intestinal tumours). Loss of membranous distribution of staining for p120(ctn) was seen in 22 (32 per cent) tumours (52 per cent of diffuse and 24 per cent of intestinal tumours). The staining pattern in the primary tumour showed no correlation with tumour type, grade, or stage, or patient survival. Of 22 lymph node metastases examined, 13 (60 per cent) showed loss of membranous staining. In conclusion, staining for p120(ctn) in gastric carcinoma and dysplasia revealed marked up-regulation of cytoplasmic staining, sometimes associated with reduced membranous expression. Up-regulation of expression of p120(ctn) has not previously been described in human epithelial malignancy. The significance of these findings is uncertain, but they may reflect a change in tyrosine kinase signal transduction pathways, and a role for p120(ctn) in ligand-induced mitogenic signalling and cell transformation.